{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:25:35Z","timestamp":1791325535292,"version":"4.3.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12013-024-01358-x","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T16:02:53Z","timestamp":1718640173000},"page":"3277-3285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ornidazole Inhibits the Angiogenesis and Migration Abilities of Non-small Cell Lung Cancer (NSCLC) via Downregulation of VEGFA\/VEGFR2\/NRP-1 and PI3K\/AKT\/mTOR Pathways"],"prefix":"10.1007","volume":"82","author":[{"given":"Gulsah","family":"Evyapan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin Cetinel","family":"Senturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Seyfettin","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"issue":"4","key":"1358_CR1","first-page":"225","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal, A., et al. (2009). Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59(4), 225\u2013249.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1358_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fonc.2017.00193","volume":"7","author":"K Inamura","year":"2017","unstructured":"Inamura, K. (2017). Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification. Frontiers in Oncology, 7, 193.","journal-title":"Frontiers in Oncology"},{"key":"1358_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-442","volume":"12","author":"Z Qian","year":"2012","unstructured":"Qian, Z., et al. (2012). Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9. BMC Cancer, 12, 442.","journal-title":"BMC Cancer"},{"issue":"1","key":"1358_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-1466-y","volume":"15","author":"S Moore","year":"2020","unstructured":"Moore, S., et al. (2020). Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients. Radiation Oncology, 15(1), 23.","journal-title":"Radiation Oncology"},{"issue":"1","key":"1358_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/31.1.9","volume":"31","author":"DI Edwards","year":"1993","unstructured":"Edwards, D. I. (1993). Nitroimidazole drugs\u2014action and resistance mechanisms. I. Mechanisms of action. Journal of Antimicrobial Chemotherapy, 31(1), 9\u201320.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"34","key":"1358_CR6","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","volume":"25","author":"H Pelicano","year":"2006","unstructured":"Pelicano, H., et al. (2006). Glycolysis inhibition for anticancer treatment. Oncogene, 25(34), 4633\u20134646.","journal-title":"Oncogene"},{"issue":"9","key":"1358_CR7","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/0006-2952(74)90362-1","volume":"23","author":"RM Ings","year":"1974","unstructured":"Ings, R. M., McFadzean, J. A., & Ormerod, W. E. (1974). The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms. Biochemical Pharmacology, 23(9), 1421\u20131429.","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"1358_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3325\/cmj.2022.63.461","volume":"63","author":"G Evyapan","year":"2022","unstructured":"Evyapan, G., et al. (2022). Ornidazole suppresses CD133+ melanoma stem cells via inhibiting hedgehog signaling pathway and inducing multiple death pathways in a mouse model. Croatian Medical Journal, 63(5), 461\u2013474.","journal-title":"Croatian Medical Journal"},{"issue":"10","key":"1358_CR9","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3390\/ijms18102021","volume":"18","author":"A Manzo","year":"2017","unstructured":"Manzo, A., et al. (2017). Angiogenesis Inhibitors in NSCLC. International Journal of Molecular Sciences, 18(10), 2021.","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"1358_CR10","first-page":"515","volume":"4","author":"RD Hall","year":"2015","unstructured":"Hall, R. D., et al. (2015). Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC). Translational Lung Cancer Research, 4(5), 515\u2013523.","journal-title":"Translational Lung Cancer Research"},{"issue":"1","key":"1358_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5322-0","volume":"19","author":"L Lian","year":"2019","unstructured":"Lian, L., et al. (2019). VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer. BMC Cancer, 19(1), 183.","journal-title":"BMC Cancer"},{"issue":"1","key":"1358_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-021-02069-4","volume":"40","author":"C Xie","year":"2021","unstructured":"Xie, C., et al. (2021). Apatinib triggers autophagic and apoptotic cell death via VEGFR2\/STAT3\/PD-L1 and ROS\/Nrf2\/p62 signaling in lung cancer. Journal of Experimental & Clinical Cancer Research, 40(1), 266.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"13","key":"1358_CR13","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.3390\/molecules26134100","volume":"26","author":"Iksen","year":"2021","unstructured":"Iksen, Pothongsrisit, S., & Pongrakhananon, V. (2021). Targeting the PI3K\/AKT\/mTOR signaling pathway in lung cancer: an update regarding potential drugs and natural products. Molecules, 26(13), 4100.","journal-title":"Molecules"},{"issue":"3","key":"1358_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1759-7714.13328","volume":"11","author":"AC Tan","year":"2020","unstructured":"Tan, A. C. (2020). Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC). Thoracic Cancer, 11(3), 511\u2013518.","journal-title":"Thoracic Cancer"},{"key":"1358_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","volume":"4","author":"J Karar","year":"2011","unstructured":"Karar, J., & Maity, A. (2011). PI3K\/AKT\/mTOR pathway in angiogenesis. Frontiers in Molecular Neuroscience, 4, 51.","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"1","key":"1358_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2217\/lmt.13.72","volume":"3","author":"H Cheng","year":"2014","unstructured":"Cheng, H., et al. (2014). Targeting the PI3K\/AKT\/mTOR pathway: potential for lung cancer treatment. Lung Cancer Management, 3(1), 67\u201375.","journal-title":"Lung Cancer Management"},{"issue":"8","key":"1358_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7150\/ijms.8128","volume":"11","author":"H Wang","year":"2014","unstructured":"Wang, H., et al. (2014). Activation of the PI3K\/Akt\/mTOR\/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells. International Journal of Medical Sciences, 11(8), 841\u2013849.","journal-title":"International Journal of Medical Sciences"},{"issue":"16","key":"1358_CR18","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2217\/pgs.15.122","volume":"16","author":"C P\u00e9rez-Ram\u00edrez","year":"2015","unstructured":"P\u00e9rez-Ram\u00edrez, C., et al. (2015). PTEN and PI3K\/AKT in non-small-cell lung cancer. Pharmacogenomics, 16(16), 1843\u20131862.","journal-title":"Pharmacogenomics"},{"issue":"16","key":"1358_CR19","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.3390\/cancers13163949","volume":"13","author":"F Rascio","year":"2021","unstructured":"Rascio, F., et al. (2021). The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: an updated review. Cancers, 13(16), 3949.","journal-title":"Cancers"},{"issue":"1","key":"1358_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms20010024","volume":"20","author":"F Wirsd\u00f6rfer","year":"2018","unstructured":"Wirsd\u00f6rfer, F., de Leve, S., & Jendrossek, V. (2018). Combining radiotherapy and immunotherapy in lung cancer: can we expect limitations due to altered normal tissue toxicity? International Journal of Molecular Sciences, 20(1), 24.","journal-title":"International Journal of Molecular Sciences"},{"issue":"13","key":"1358_CR21","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","volume":"28","author":"A Aup\u00e9rin","year":"2010","unstructured":"Aup\u00e9rin, A., et al. (2010). Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. Journal of Clinical Oncology, 28(13), 2181\u20132190.","journal-title":"Journal of Clinical Oncology"},{"issue":"18","key":"1358_CR22","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2217\/fon-2015-0055","volume":"12","author":"A Condoluci","year":"2016","unstructured":"Condoluci, A., et al. (2016). Impact of smoking on lung cancer treatment effectiveness: a review. Future Oncology, 12(18), 2149\u20132161.","journal-title":"Future Oncology"},{"issue":"3","key":"1358_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","volume":"2","author":"N Nishida","year":"2006","unstructured":"Nishida, N., et al. (2006). Angiogenesis in cancer. Vascular Health and Risk Management, 2(3), 213\u2013219.","journal-title":"Vascular Health and Risk Management"},{"issue":"10","key":"1358_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/14728222.2017.1371137","volume":"21","author":"D Frezzetti","year":"2017","unstructured":"Frezzetti, D., et al. (2017). VEGF as a potential target in lung cancer. Expert Opinion on Therapeutic Targets, 21(10), 959\u2013966.","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"1","key":"1358_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79907-6","volume":"11","author":"WY Jung","year":"2021","unstructured":"Jung, W. Y., Min, K. W., & Oh, Y. H. (2021). Increased VEGF-A in solid type of lung adenocarcinoma reduces the patients\u2019 survival. Scientific Reports, 11(1), 1321.","journal-title":"Scientific Reports"},{"issue":"6","key":"1358_CR26","first-page":"669","volume":"26","author":"M Ding","year":"2014","unstructured":"Ding, M., et al. (2014). Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significance. Chinese Journal of Cancer Research, 26(6), 669\u2013677.","journal-title":"Chinese Journal of Cancer Research"},{"issue":"1","key":"1358_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000321905","volume":"86","author":"PA Videira","year":"2011","unstructured":"Videira, P. A., et al. (2011). Effects of bevacizumab on autocrine VEGF stimulation in bladder cancer cell lines. Urologia Internationalis, 86(1), 95\u2013101.","journal-title":"Urologia Internationalis"},{"issue":"1-2","key":"1358_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11010-010-0562-y","volume":"345","author":"Y Chen","year":"2010","unstructured":"Chen, Y., et al. (2010). Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism. Molecular and Cellular Biochemistry, 345(1-2), 77\u201389.","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"6","key":"1358_CR29","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.0022-202X.2004.23460.x","volume":"123","author":"J Graells","year":"2004","unstructured":"Graells, J., et al. (2004). Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling. Journal of Investigative Dermatology, 123(6), 1151\u20131161.","journal-title":"Journal of Investigative Dermatology"},{"issue":"22","key":"1358_CR30","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.1158\/1078-0432.CCR-13-1093","volume":"19","author":"Q Li","year":"2013","unstructured":"Li, Q., et al. (2013). Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer. Clinical Cancer Research, 19(22), 6252\u20136260.","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"1358_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1158\/2159-8290.CD-14-0921","volume":"5","author":"JL Van Nostrand","year":"2015","unstructured":"Van Nostrand, J. L., et al. (2015). The p53 target gene SIVA enables non-small cell lung cancer development. Cancer Discovery, 5(6), 622\u2013635.","journal-title":"Cancer Discovery"},{"issue":"12","key":"1358_CR32","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1177\/1947601911407325","volume":"1","author":"MM Georgescu","year":"2010","unstructured":"Georgescu, M. M. (2010). PTEN tumor suppressor network in PI3K-Akt pathway control. Genes Cancer, 1(12), 1170\u20131177.","journal-title":"Genes Cancer"},{"issue":"8","key":"1358_CR33","doi-asserted-by":"publisher","first-page":"7409","DOI":"10.1007\/s11033-022-07536-5","volume":"49","author":"S Akar","year":"2022","unstructured":"Akar, S., Donmez-Altuntas, H., & Hamurcu, Z. (2022). \u03b2-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene. Molecular Biology Reports, 49(8), 7409\u20137415.","journal-title":"Molecular Biology Reports"},{"issue":"7301","key":"1358_CR34","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1136\/bmj.322.7301.1536","volume":"322","author":"AG Renehan","year":"2001","unstructured":"Renehan, A. G., Booth, C., & Potten, C. S. (2001). What is apoptosis, and why is it important? BMJ, 322(7301), 1536\u20131538.","journal-title":"BMJ"},{"issue":"4","key":"1358_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore, S. (2007). Apoptosis: a review of programmed cell death. Toxicologic Pathology, 35(4), 495\u2013516.","journal-title":"Toxicologic Pathology"},{"issue":"2","key":"1358_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3892\/ol.2013.1725","volume":"7","author":"J Yin","year":"2014","unstructured":"Yin, J., et al. (2014). miR-101 sensitizes A549 NSCLC cell line to CDDP by activating caspase 3-dependent apoptosis. Oncology Letters, 7(2), 461\u2013465.","journal-title":"Oncology Letters"}],"updated-by":[{"DOI":"10.1007\/s12013-024-01501-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000}}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01358-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T17:07:42Z","timestamp":1732036062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01358-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1358"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01358-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12013-024-01501-8","asserted-by":"object"}]},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]},"assertion":[{"value":"10 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12013-024-01501-8","URL":"https:\/\/doi.org\/10.1007\/s12013-024-01501-8","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}